Advanced NSCLC Immunotherapy - Checkpoint Inhibitors

Sort by:
Relevance Thumbs Up Comments Views Newest Oldest
19:01

Insights from ELCC 2025

ELCC 2025 Summary: Overcoming Primary Resistance to NSCLC Immunotherapy

FEATURING Roberto Ferrara
  • 1 view
  • April 17, 2025
08:27

Insights from ELCC 2025

ELCC 2025 Insights: Does Timing of IO Infusion Influence Clinical Outcomes in Advanced NSCLC?

FEATURING Ivánia Furtado
  • April 17, 2025
08:13

Insights from ELCC 2025

ELCC 2025 Insights: Phase 2 Study of Telomere-Targeting Agent THIO Sequenced by Cemiplimab in ICI-Resistant Advanced NSCLC - Interleukin-6 as a Potential Predictive Biomarker

FEATURING Tomasz Jankowski
  • April 17, 2025
03:24

ecancer

ELCC 2025 Insights: KEYNOTE-799 - Pembro + cCRT in Unresectable Locally Advanced NSCLC

FEATURING Martin Reck
  • 4 views
  • April 14, 2025
13:14

Insights from ELCC 2025

ELCC 2025 Summary: Managing Locally Advanced NSCLC With Poor Lung Function - The Role of RT in the Era of IO

FEATURING Corinne Faivre-Finn
  • 2 views
  • April 11, 2025
03:01

ecancer

ELCC 2025 Summary: Preventing Moderate to Severe Dermatologic AEs in 1L EGFRm Advanced NSCLC Treated With Amivantamab + Lazertinib

FEATURING Nicolas Girard
  • 8 views
  • April 11, 2025
06:03

ecancer

ELCC 2025 Insights: Phase 3 MK-3475A-D77 Trial - SC vs. IV Pembro + Chemo in mNSCLC

FEATURING Enriqueta Felip
  • 4 views
  • April 11, 2025
12:21

Insights from ELCC 2025

ELCC 2025 Insights: Pembro + CCRT in Unresectable Locally Advanced NSCLC - Final Analysis of KEYNOTE-799

FEATURING Sara Ramella
  • 44 views
  • April 9, 2025
16:41

Insights from ELCC 2025

ELCC 2025 Summary: Targeted Treatment of RAS-Mutant NSCLC: Adagrasib + Pembro or Fulzerasib + Cetuximab for 1L KRAS G12C; Daraxonrasib Monotherapy for 2L+ Pan-RAS G12X-Cm+ Disease

FEATURING Joop Langen
  • 9 views
  • April 9, 2025
88:00

The Immuno-Oncology Clinical Network (IOCN)

Cases of Immune-Related Hepatitis and Cholangitis in Melanoma and NSCLC

FEATURING Anna Olsson-Brown, Guy Kendall, Ricky Frazer, Trudy Guinan, Lucia Possamai, Claire Barlow
  • 11 views
  • April 4, 2025
19:57

GRACE

Targeting KRAS and BRAF in NSCLC

FEATURING Jorge Nieva
  • 24 views
  • April 1, 2025
04:58

Rohit Singh

Tarlatamab: A BiTE Therapy for SCLC

  • 4 views
  • April 1, 2025
06:05

GRACE

Patient Selection Strategies for Optimal Metastatic NSCLC Treatment

FEATURING Puneeth Lyengar
  • 13 views
  • March 27, 2025
03:50

GRACE

LCT for Limited Metastatic NSCLC: NRG-LU002 Limitations & Summary

FEATURING Puneeth Lyengar
  • 2 views
  • March 27, 2025
09:35

GRACE

LCT for Limited Metastatic NSCLC: NRG-LU002 Results

FEATURING Puneeth Lyengar
  • 1 view
  • March 27, 2025
51:33

The Immuno-Oncology Clinical Network (IOCN)

Case-Based Expert Panel and Q&A on Managing Immune-Related Endocrinopathies in NSCLC and Melanoma

FEATURING Sherwin Criseno, Alexandra Johnson, Trudy Guinan, Ricky Frazer
  • 18 views
  • March 25, 2025
88:26

The Immuno-Oncology Clinical Network (IOCN)

Immune Checkpoint Inhibitors in Advanced NSCLC & Metastatic Melanoma Cases: A Focus on Triple M Syndrome - Panel Discussion

FEATURING Anna Olsson-Brown, Adam Chapman, Clare Barlow, Aisling Carr, Ricky Frazer
  • 12 views
  • March 21, 2025
11:35

Total Health

Neoadjuvant vs. Adjuvant: A New Paradigm for NSCLC

FEATURING David Carbone
  • 216 views
  • March 8, 2025
  • 1
04:18

Total Health

Preoperative TKIs in Neoadjuvant NSCLC

FEATURING David Carbone
  • 69 views
  • March 8, 2025
41:10

UCLA Health

Unmet Treatment Needs of Chemo-IO in Resectable NSCLC

FEATURING Jay M. Lee
  • 64 views
  • March 8, 2025
31:15

UCLA Health

Current Landscape of Neoadjuvant, Perioperative, and Adjuvant IO in Resectable NSCLC

FEATURING Jay M. Lee
  • 132 views
  • March 8, 2025
  • 2
05:21

GRACE

Targeted Therapies for Unresectable Stage 3 NSCLC

FEATURING Angel Qin
  • 9 views
  • February 28, 2025
04:27

GRACE

The Efficacy of Immunotherapies for EGFRm Lung Cancer

FEATURING Ibiayi Dagogo-Jack, Julia Rotow, Misty Shields, Alissa Cooper, Angel Qin
  • 125 views
  • February 24, 2025
04:51

GRACE

The Future of Lung Cancer Treatment: What’s on the Horizon?

FEATURING Julia Rotow, Ibiayi Dagogo-Jack, Misty Shields, Alissa Cooper, Angel Qin
  • 93 views
  • February 24, 2025
24:16

International Cancer Imaging Society (ICIS)

Imaging of Precision Therapy in Lung Cancer

FEATURING Mizuki Nishino
  • 54 views
  • February 6, 2025
  • 1

Advanced NSCLC Immunotherapy - Checkpoint Inhibitors

No subtopics